Test Price
7,500 AED✅ Home Collection Available
ATAC‑Seq Analysis in UAE | 7500 AED | DHA‑Licensed Epigenomic Profiling
Executive Summary & Core Metrics
Clinical Excellence & Premium Service
- Accuracy & Resolution: Genome‑wide nucleotide‑level chromatin accessibility mapping via ISO 9001:2015 accredited Next‑Generation Sequencing and bioinformatics pipelines.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM – 11 PM) for peripheral whole blood or extracted DNA specimens.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by DHA‑licensed expert.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
ATAC‑Seq (Assay for Transposase‑Accessible Chromatin using Sequencing) is a revolutionary epigenomic assay that identifies genome‑wide open chromatin regions using Tn5 transposase‑mediated tagmentation, enabling precise mapping of active regulatory elements. In the UAE, our DHA‑anchored service delivers clinically robust, research‑grade results within 10 weeks, supporting oncologists, rheumatologists, and translational researchers.
| Feature | Our ATAC‑Seq Test | Closest Alternative (ChIP‑Seq) |
|---|---|---|
| Methodology | Tn5 Transposase tagmentation, high‑throughput NGS | Antibody‑based DNA pull‑down & sequencing |
| Precision / Resolution | Nucleotide‑level open chromatin maps, genome‑wide | Targeted histone marks; lower spatial resolution |
| Turnaround Time | 10 weeks | 12–16 weeks |
| Data Depth | 50M reads/sample, multi‑omics integration ready | 20–40M reads, limited dynamic range |
Physician Insight & Safety Protocols
“ATAC‑Seq provides a genome‑wide view of chromatin accessibility, offering critical insights into regulatory element activity. However, these results must be interpreted within the full clinical and molecular context of the patient. I recommend combining this assay with standard genetic tests and clinical evaluation to ensure accurate translational application.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration: 9294403
Medication Advisory & Exclusion Criteria
⚠ Important Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide venous blood sample; active infection at collection site; known severe bleeding disorder; pregnancy (unless specifically approved by referring physician).
- Red Flags (Seek Immediate Care): Dizziness, fainting, persistent bleeding, or signs of infection (redness, swelling) after venipuncture.
Patient FAQ & Clinical Guidance
1. What is ATAC‑Seq analysis and how is it performed?
ATAC‑Seq analysis is a cutting‑edge next‑generation sequencing method that rapidly maps accessible chromatin across the genome using a transposase enzyme, providing a snapshot of epigenetic regulation and gene expression potential. A venous blood sample or extracted DNA is processed in our ISO‑certified lab; the Tn5 transposase simultaneously cuts and tags open DNA regions, enabling high‑resolution detection of regulatory elements.
2. Why is ATAC‑Seq used in oncology and rheumatology research?
ATAC‑Seq enables identification of dysregulated chromatin regions in cancer and autoimmune diseases, revealing potential biomarkers and therapeutic targets with high precision for oncologists and rheumatologists. It uncovers the epigenetic landscape underlying tumor heterogeneity, drug resistance, and inflammatory pathways, facilitating personalized medicine approaches.
3. How long does it take to receive results and what do they mean?
Results are delivered within 10 weeks, accompanied by telephonic guidance from our clinical team to interpret chromatin accessibility peaks and link them to disease phenotypes, ensuring informed medical decision‑making. The report includes quality metrics, genome browser tracks, and a summary of differentially accessible regions relevant to your clinical question.
UAE Regulatory & Data Privacy Adherence
All clinical and genomic data handling at DNA Labs UAE strictly adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, clinical safety, and medical liability are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our ISO 9001:2015 certified processes guarantee the highest standards of data security and patient confidentiality.
Clinical & Logistical Metadata
| Test Name | ATAC‑Seq (Assay for Transposase‑Accessible Chromatin using Sequencing) |
| Price (AED) | 7,500 |
| Turnaround Time | 10 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) or Extracted DNA – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM – 11 PM |
| Methodology Used | Tn5 Transposase Tagmentation, High‑Throughput Next‑Generation Sequencing |
| ICD‑10‑CM Code | Z13.9 |
| LOINC Code | 94222-8 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians